LFST (LifeStance Health Group, Inc.) Stock Financials & Earnings | Market Cap Arena

LFST (LifeStance Health Group, Inc.) Stock Financials & Earnings | Market Cap Arena

LFSTLifeStance Health Group, Inc.

Mkt Cap$3B

Healthcare·Medical - Care Facilities·🇺🇸 United States·NASDAQ

Revenue (TTM)$1.4B

Net Income (TTM)$10M

EPS (TTM)$0.02

Free Cash Flow (TTM)$146M

Gross Margin30.4%

Op. Margin1.7%

Net Margin0.7%

FCF Margin10.3%

P/S Ratio (TTM)1.9x

P/E Ratio (TTM)280.1x

YoY Rev Growth+13.9%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$253M	$70M	-$34M
Q2 23	$260M	$73M	-$48M
Q3 23	$263M	$76M	-$74M
Q4 23	$281M	$83M	-$32M
Q1 24	$300M	$95M	-$17M
Q2 24	$312M	$98M	-$16M
Q3 24	$313M	$100M	$47K
Q4 24	$325M	$109M	$1M
Q1 25	$333M	$110M	$2M
Q2 25	$345M	$94M	-$3M
Q3 25	$364M	$117M	$7M
Q4 25	$382M	$113M	$18M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q1 23	3.0x	—
Q2 23	2.8x	—
Q3 23	2.7x	—
Q4 23	2.6x	—
Q1 24	2.5x	—
Q2 24	2.3x	—
Q3 24	2.2x	—
Q4 24	2.2x	—
Q1 25	2.1x	—
Q2 25	2.1x	—
Q3 25	2.0x	—
Q4 25	1.9x	280.1x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$8M	-$16M
Q2 23	-$434K	-$12M
Q3 23	-$25M	-$35M
Q4 23	$17M	$5M
Q1 24	-$22M	-$27M
Q2 24	$44M	$39M
Q3 24	$23M	$18M
Q4 24	$62M	$56M
Q1 25	-$3M	-$10M
Q2 25	$64M	$57M
Q3 25	$27M	$17M
Q4 25	$58M	$83M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$8M
Q2 23	$12M
Q3 23	$10M
Q4 23	$11M
Q1 24	$5M
Q2 24	$5M
Q3 24	$5M
Q4 24	$6M
Q1 25	$7M
Q2 25	$8M
Q3 25	$10M
Q4 25	$25M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+24.4%	+7.0%
Q2 23	+23.9%	+14.1%
Q3 23	+20.8%	+31.5%
Q4 23	+22.3%	+13.6%
Q1 24	+18.9%	+10.6%
Q2 24	+20.3%	+6.6%
Q3 24	+19.0%	-7.3%
Q4 24	+16.0%	+3.7%
Q1 25	+10.8%	+4.5%
Q2 25	+10.6%	+6.1%
Q3 25	+16.3%	+14.0%
Q4 25	+17.4%	+12.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$24M	9.4%
Q2 23	$33M	12.7%
Q3 23	$22M	8.2%
Q4 23	$21M	7.5%
Q1 24	$21M	6.9%
Q2 24	$25M	7.9%
Q3 24	$15M	4.8%
Q4 24	$16M	5.0%
Q1 25	$19M	5.6%
Q2 25	$21M	6.1%
Q3 25	$18M	5.0%
Q4 25	-$58M	-15.2%

OpEx Breakdown

Quarter	G&A
Q1 23	$85M
Q2 23	$102M
Q3 23	$131M
Q4 23	$93M
Q1 24	$89M
Q2 24	$95M
Q3 24	$85M
Q4 24	$94M
Q1 25	$94M
Q2 25	$97M
Q3 25	$96M
Q4 25	$95M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$68M	$0	$68M
Q2 23	$80M	$0	$80M
Q3 23	$43M	$0	$43M
Q4 23	$79M	$0	$79M
Q1 24	$49M	$0	$49M
Q2 24	$87M	$0	$87M
Q3 24	$103M	$0	$103M
Q4 24	$155M	$0	$155M
Q1 25	$134M	$0	$134M
Q2 25	$189M	$0	$189M
Q3 25	$204M	$0	$204M
Q4 25	$249M	$0	$249M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	361M	-4.0%
Q2 23	363M	+0.6%
Q3 23	372M	+2.6%
Q4 23	379M	+1.7%
Q1 24	376M	-0.6%
Q2 24	379M	+0.8%
Q3 24	379M	-0.2%
Q4 24	383M	+1.1%
Q1 25	391M	+2.1%
Q2 25	385M	-1.4%
Q3 25	389M	+1.0%
Q4 25	391M	+0.6%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 19	—	—
FY 20	—	—
FY 21	$139K	5K
FY 22	$110K	8K
FY 23	$113K	9K
FY 24	$122K	10K
FY 25	$130K	11K